Results 21 to 30 of about 4,965,597 (147)

Capsid

open access: yes, 2011
Capsid is a water-jet cut optiwhite glass and perspex artwork suspended in a grid-like formation by vertical nylon wires, created in an attempt to visualize a viral capsid in the process of self-assembly or ...
Rennie, Colin
core   +5 more sources

Structural basis of receptor usage by the engineered capsid AAV-PHP.eB

open access: yesMolecular Therapy - Methods & Clinical Development, 2022
Adeno-associated virus serotype 9 (AAV9) is a promising gene therapy vector for treating neurodegenerative diseases due to its ability to penetrate the blood-brain barrier. PHP.eB was engineered from AAV9 by insertion of a 7-amino acid peptide and point mutation of neighboring residues, thereby enhancing potency in the central nervous system.
Seongmin Jang   +4 more
openaire   +5 more sources

Novel Chimeric Gene Therapy Vectors Based on Adeno-Associated Virus and Four Different Mammalian Bocaviruses

open access: yesMolecular Therapy: Methods & Clinical Development, 2019
Parvoviruses are highly attractive templates for the engineering of safe, efficient, and specific gene therapy vectors, as best exemplified by adeno-associated virus (AAV).
Julia Fakhiri   +14 more
doaj   +1 more source

Chondroitin Sulfate is the Primary Receptor for a Peptide-Modified AAV That Targets Brain Vascular Endothelium In Vivo

open access: yesMolecular Therapy: Nucleic Acids, 2014
Recently, we described a peptide-modified AAV2 vector (AAV-GMN) containing a capsid-displayed peptide that directs in vivo brain vascular targeting and transduction when delivered intravenously.
James C Geoghegan   +5 more
doaj   +1 more source

Non-canonical amino acid incorporation into AAV5 capsid enhances lung transduction in mice

open access: yesMolecular Therapy: Methods & Clinical Development, 2023
Gene therapy using recombinant adeno-associated virus (rAAV) relies on safe, efficient, and precise in vivo gene delivery that is largely dependent on the AAV capsid.
Hao Chang   +8 more
doaj   +1 more source

Capsid-Specific Antibody Responses of Domestic Pigs Immunized with Low-Virulent African swine fever virus

open access: yes, 2023
Excel file contains the raw data (P/N ratios) and results of statistical analyses that were used to plot the figures outlined in the publication Tng et al.
Egle Pauletto (14720951)   +4 more
core   +1 more source

Adeno-Associated Virus (AAV) Gene Delivery: Dissecting Molecular Interactions upon Cell Entry

open access: yesViruses, 2021
Human gene therapy has advanced from twentieth-century conception to twenty-first-century reality. The recombinant Adeno-Associated Virus (rAAV) is a major gene therapy vector. Research continues to improve rAAV safety and efficacy using a variety of AAV
Edward E. Large   +4 more
doaj   +1 more source

Adipose Tissue: An Emerging Target for Adeno-associated Viral Vectors

open access: yesMolecular Therapy: Methods & Clinical Development, 2020
Adipose tissue is one of the largest organs, playing important roles in physiology and pathologies of multiple diseases. However, research related to adeno-associated virus (AAV) targeting adipose tissue has been left far behind studies carried out in ...
Rhiannon Bates, Wei Huang, Lei Cao
doaj   +1 more source

A beta-herpesvirus with fluorescent capsids to study transport in living cells. [PDF]

open access: yes, 2012
Fluorescent tagging of viral particles by genetic means enables the study of virus dynamics in living cells. However, the study of beta-herpesvirus entry and morphogenesis by this method is currently limited.
Lisa Marcinowski   +49 more
core   +2 more sources

The Cold Case Files of rAAV Capsid Influence on Transduction: New Leads

open access: yesViruses
Adeno-associated virus (AAV) is a prevalent vector in viral gene therapy. Given its importance, significant efforts focus on engineering the capsid residues on the exterior surface to increase cell/tissue-specific binding to cellular receptors or to ...
Sara K. Powell
doaj   +1 more source

Home - About - Disclaimer - Privacy